Eosinophil activation in preterm infants with lung disease

Acta Paediatrica, International Journal of Paediatrics

Volumn 96, Issue 1, 2007, Pages 23-28

  Broström, E Berggren ^a   Katz Salamon, M ^a   Lundahl, J ^a   Hallden G ^a   Winbladh, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

BPD; ECP; Eosinophil; Inflammation; Preterm

Indexed keywords

BIOCHEMICAL MARKER; BUDESONIDE; CD9 ANTIGEN; EOSINOPHIL CATIONIC PROTEIN; MEMBRANE ANTIGEN;

ARTICLE; BLOOD SAMPLING; CELL ACTIVATION; CELL ACTIVITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHIL COUNT; FEMALE; FLUORESCENCE; HUMAN; INFANT; LUNG DYSPLASIA; MALE; NEUTROPHIL COUNT; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; VENOUS BLOOD;

ANTIGENS, CD; BIOLOGICAL MARKERS; BRONCHODILATOR AGENTS; BRONCHOPULMONARY DYSPLASIA; BUDESONIDE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MEMBRANE GLYCOPROTEINS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SEVERITY OF ILLNESS INDEX;

EID: 33847206812     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2006.00002.x     Document Type: Article

References (31)

1. Northway W, Rosan R, Porter D. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Eng J Med 1967;267:357-68.
2. Bancalari E. Bronchopulmonary dysplasia: clinical presentation. J Pediatr 1979;95:819-23.
3. Northway W. An introduction to bronchopulmonary dysplasia. Clin Perinatol 1992;19:489-95.
4. Parker R, Lindstrom D, Cotton R. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia. Pediatrics 1992;90:663-8.
5. Bancalari E. Pathogenesis of bronchopulmonary dysplasia: an overview. In: Bancalari E, Stocker J., editors. Bronchopulmonary dysplasia. Washington, DC: Hemisphere, 1988:3-15.
6. Cooke R. Factors associated with chronic lung disease in preterm infants. Arch Dis Child 1991;66:776-9.
7. Pelkonen AS, Suomalainen H, Hallman M, Turpeinen M. Peripheral blood lymphocyte subpopulations in schoolchildren born very preterm. Arch Dis Child Fetal Neonatal Ed 1999;81;188-93.
8. Speer CP. Inflammatory mechanism in neonatal chronic lung disease. Eur J Pediatr 1999;158(Suppl. 1):18-22.
9. Huang HC,Yang MY, Huang CB,Yang KD. Profiles of inflammatory cytokines in bronchoalveolar lavage fluid from premature infants with respiratory distress disease. J Microbiol Immunol Infect 2000;33:19-24.
10. Jónsson B, Tullus K, Brauner A, Lu Y, Noack G. Early increase of TNF-α and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lungdisease in preterm infants. Arch Dis Child 1997;77:F198-201.
11. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9
12. Cole CH, Fiascone JM. Strategies for prevention of neonatal chronic lung disease. Semin Perinatol 2000;24:445-6.
13. Guidelines for the diagnosis and mangementof asthma. J Allergy Clin Immunol 1991;88:425-534.
14. Tiddens H, Silverman M, Bush. The role of inflammation in airway disease: remodeling. Am J Respir Crit Care Med 2000;162:7-10.
15. Motojima S, Frigad E, Loegering DA, Gleich GJ. Toxicity of eosinophil cationic proteins for guineapig tracheal epithelium in vitro. Am Rev Respir Dis 1989;139:801-5.
16. Hashino M, Nakamura Y. Relationship between activated eosinophils of the bronchial mucosa and serum eosinophil cationic protein in atopic asthma. Int Arch Allergy Immunol 1997;112:59-64.
17. Fernvik E, Halldén G, Hed J, Lundahl J. Intracellular and surface distrubition of CD9 in human eosinophils. APMIS 1995;103:669-706.
18. Raghavender B, Smith J. Eosinophil cationic protein in tracheal aspirates of preterm infants with Bronchopulmonary dysplasia. J Pediatr 1997;130:944-7
19. Yamamoto C, Kojima T, Hattori K, Nogi S, Imamura H, Tsubura A, Kobayashi Y. Eosinophilia in premature infants: correlation with chronic lung disease. Acta Paediatr 1996;85:1232-5.
20. Clement A, Chadelat K, Sardet A, Grimfeld A, Tournier G. Alveolar macrophage status in bronchopulmonary dysplasia. Pediatr Res 1988;23:470-83.
21. Boyum A. Separation of lymphocytes, granulocytes and monocytes from human blood using iodinated density gradient media. In: Di Sabato G, Langone J, Van Vunakis H, editors. Methods in enzymologi. Academic Press Inc, 1984:88-102.
22. Halldén G, Andersson U, Hed J, Johansson S:G:O: A new membrane permeabilization method for the detection of intracellular antigens by flowcytometri. J Immunol Methods 1989;124:103-9.
23. Halldén G, Hed J. The FOG method-a new approach to detecting activated eosinophils. ACI News 1993;5:139-43.
24. Zagai U, Sköld CM, Trulson A, Venge P, Lundahl J. The effect of eosinophils on collagen gel contraction and implications for tissue remodeling. Clin Exp Immunol, 2004;135:427-33.
25. Gibson EL, Vaucher Y, Corrigan J Jr. Eosinophilia in premature infants: relationship to weight gain. J Pediatr 1979;95:99-101.
26. Bhat AM, Scanlon JW. The pattern of eosinophilia in premature infants. A prospective study in premature infants using the absolute eosinophil count. J Pediatr 1981;98(4):612.
27. Moshfegh A, Lothian C, Halldén G, Marchini G, Lagercrantz H, Lundahl J. Neonatal eosinophils possess efficient eotaxin/IL-5 and N-formyl-methionyl-leucyl-phenylalanine-induced transmigration in vitro. Pediatr Res 2005;58:138-42.
28. Hed J, Halldén G. Counts of activated blood eosinophils for monitoring asthma. Allergy 1993;48:87-93.
29. Nopp A Lundahl J, Hallden G. Quantitative, rather than qualitative, differences in CD69 upregulation in human blood eosinophils upon activation with selected stimuli. Allergy 2000;55:148-56.
30. Fernvik E, Lundahl J, Magnusson CG, Hallden G. The effect of in vitro activation and platelet interaction on the CD9 distribution and adhesion properties of human eosinophils. Inflamm Res 1999;48:28-35.
31. Krug N, Napp U, Enander I, Eklund E, Rieger CH, Schauer U. Intracellular expression and serum levels of eosinophil peroxidase (EPO) and eosinophil cationic protein in asthmatic children. Clin Exp Allergy 1999;29:1507-15.